Aptevo Therapeutics Inc expected to post a loss of $1.12 a share - Earnings Preview

Aptevo Therapeutics

07/08/2023 16:53

* Aptevo Therapeutics Inc  APVO.OQ   APVO.O  is expected
to show
no change in quarterly revenue when it reports  results on
August 9 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Aptevo Therapeutics
Inc
is for a loss of $1.12 per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Aptevo
Therapeutics Inc is $18​, above​ its last closing price
of $0.59. ​​​

This summary was machine generated August 7 at 15:53 GMT.  All
figures in US dollars  unless otherwise stated